Beta Bionics, Inc.

BBNX Nasdaq CIK: 0001674632

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 11 HUGHES, IRVINE, CA, 92618
Mailing Address 11 HUGHES, IRVINE, CA, 92618
Phone 949-427-7785
Fiscal Year End 1231
EIN 475386878

Financial Overview

FY2024

-$44.10M
Net Income
$149.65M
Total Assets
-$170.03M
Stockholders' Equity
$30.43M
Cash & Equivalents
$-8.31
EPS

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 12, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 10, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 10, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 9, 2026 View on SEC
8-K Current report of material events January 30, 2026 View on SEC
4 Insider stock transaction report January 14, 2026 View on SEC
4 Insider stock transaction report January 14, 2026 View on SEC
4 Insider stock transaction report January 14, 2026 View on SEC
4 Insider stock transaction report January 14, 2026 View on SEC
4 Insider stock transaction report January 14, 2026 View on SEC

Material Events

8-K Legal Issue January 30, 2026
High Impact
  • The FDA Warning Letter does not stop Beta Bionics from selling or distributing its current products.
  • The Warning Letter does not block the planned launch of their new "Mint" product.
View Analysis

Insider Trading

STRONG SELL 5 insiders 11 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.